MENU
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TBPH stock forecast, quote, news & analysis

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for TBPH with price predictions
Nov 03, 2026

TBPH sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for TBPH moved above the 200-day moving average on October 26, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

TBPH moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TBPH crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for TBPH entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Industry
Pharmaceuticals Other
Address
C/O Theravance Biopharma US, LLC
Phone
+1 650 808-6000
Employees
90
Web
https://www.theravance.com
TBPH sees its 50-day moving average cross bullishly above its 200-day moving average